Gilles Martin - Eurofins Scientific Chairman CEO

ERF Stock  EUR 59.88  1.72  2.96%   

Insider

Gilles Martin is Chairman CEO of Eurofins Scientific SE
Age 60
Phone352 26 18 53 20
Webhttps://www.eurofins.com

Eurofins Scientific Management Efficiency

The company has return on total asset (ROA) of 0.075 % which means that it generated a profit of $0.075 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1521 %, meaning that it generated $0.1521 on every $100 dollars invested by stockholders. Eurofins Scientific's management efficiency ratios could be used to measure how well Eurofins Scientific manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.08 B in total debt with debt to equity ratio (D/E) of 115.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Eurofins Scientific has a current ratio of 1.16, suggesting that it is not liquid enough and may have problems paying out its financial obligations in time and when they become due. Debt can assist Eurofins Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Eurofins Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Eurofins Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Eurofins to invest in growth at high rates of return. When we think about Eurofins Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Patrick RouvilloisEdenred SA
51
Solne ZammitoEdenred SA
N/A
Julien TanguyEdenred SA
50
John MackaySartorius Stedim Biotech
61
Olivier RigaudyTeleperformance SE
64
Eric SauvageEdenred SA
51
Dev MudaliarTeleperformance SE
N/A
Craig MarksIpsen SA
N/A
Joachim KreuzburgSartorius Stedim Biotech
58
Emmanuelle ChatelainEdenred SA
48
Leigh RyanTeleperformance SE
70
Petra KirchhoffSartorius Stedim Biotech
54
Virginie HeuzTeleperformance SE
N/A
Alan WintersTeleperformance SE
N/A
Yan MDIpsen SA
56
Agustin GrisantiTeleperformance SE
50
Gwenan WhiteIpsen SA
N/A
Yannis TourcomanisTeleperformance SE
N/A
Luciana CemerkaTeleperformance SE
N/A
MarieLaurence BouchonEdenred SA
48
JeanBernard HamelEdenred SA
62
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. EUROFINS SCIENT operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 43819 people. Eurofins Scientific SE (ERF) is traded on Euronext Paris in France and employs 61,000 people.

Management Performance

Eurofins Scientific Leadership Team

Elected by the shareholders, the Eurofins Scientific's board of directors comprises two types of representatives: Eurofins Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eurofins. The board's role is to monitor Eurofins Scientific's management team and ensure that shareholders' interests are well served. Eurofins Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eurofins Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gilles Martin, Chairman CEO
David Bryant, Sr America
Yvoine Remy, VP Europe
Rajesh Saigal, Ex Asia
Laurent Lebras, Group Director
Sandra Hoeylaerts, Chief Officer
Joachim Reichelt, VP Europe
Gabriel Julia, VP Europe
Valerie Hanote, Ex Director
Timothy Oostdyk, Genomics BioPharma

Eurofins Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Eurofins Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eurofins Scientific SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Note that the Eurofins Scientific information on this page should be used as a complementary analysis to other Eurofins Scientific's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Eurofins Stock analysis

When running Eurofins Scientific's price analysis, check to measure Eurofins Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurofins Scientific is operating at the current time. Most of Eurofins Scientific's value examination focuses on studying past and present price action to predict the probability of Eurofins Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurofins Scientific's price. Additionally, you may evaluate how the addition of Eurofins Scientific to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Please note, there is a significant difference between Eurofins Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eurofins Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eurofins Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.